upa Search Results


91
MedChemExpress mouse plau upa
Mouse Plau Upa, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse plau upa/product/MedChemExpress
Average 91 stars, based on 1 article reviews
mouse plau upa - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

93
R&D Systems upa
<t>uPA</t> protein expression is mutp53-dependent. Protein expression of uPA encoded by the RNA-seq identified gene PLAU, was assessed <t>in</t> <t>p53-depleted</t> and control conditions. (A) Western blot of A549, H2087, H441, H2110 and H2009 cells transfected with negative control or siRNA directed against p53 (25 nM). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is shown as a loading control. (B) qRT–PCR was performed to evaluate mRNA expression of PLAU after depletion of p53 by siRNA. mRNA expression values are normalized to GAPDH and siCtrl condition within each cell line. (C) Protein and conditioned media were harvested from cells after overnight incubation in reduced-serum conditions. Nitrocellulose membranes were stained with Ponceau S dye to visualize protein bands for loading control. Protein expression of pro-uPA (49 kDa) and its cleaved and activated forms B-chain (33 kDa) and A-chain (19 kDa) are shown in cell lysates and conditioned media. (D) Protein and E. mRNA expression of uPA (PLAU) following depletion of V157F mutp53 by siRNA.
Upa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/upa/product/R&D Systems
Average 93 stars, based on 1 article reviews
upa - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology monoclonal antibody against mouse upa
<t>uPA</t> protein expression is mutp53-dependent. Protein expression of uPA encoded by the RNA-seq identified gene PLAU, was assessed <t>in</t> <t>p53-depleted</t> and control conditions. (A) Western blot of A549, H2087, H441, H2110 and H2009 cells transfected with negative control or siRNA directed against p53 (25 nM). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is shown as a loading control. (B) qRT–PCR was performed to evaluate mRNA expression of PLAU after depletion of p53 by siRNA. mRNA expression values are normalized to GAPDH and siCtrl condition within each cell line. (C) Protein and conditioned media were harvested from cells after overnight incubation in reduced-serum conditions. Nitrocellulose membranes were stained with Ponceau S dye to visualize protein bands for loading control. Protein expression of pro-uPA (49 kDa) and its cleaved and activated forms B-chain (33 kDa) and A-chain (19 kDa) are shown in cell lysates and conditioned media. (D) Protein and E. mRNA expression of uPA (PLAU) following depletion of V157F mutp53 by siRNA.
Monoclonal Antibody Against Mouse Upa, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal antibody against mouse upa/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
monoclonal antibody against mouse upa - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

92
R&D Systems plau mab1310 primary antibodies
<t>uPA</t> protein expression is mutp53-dependent. Protein expression of uPA encoded by the RNA-seq identified gene PLAU, was assessed <t>in</t> <t>p53-depleted</t> and control conditions. (A) Western blot of A549, H2087, H441, H2110 and H2009 cells transfected with negative control or siRNA directed against p53 (25 nM). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is shown as a loading control. (B) qRT–PCR was performed to evaluate mRNA expression of PLAU after depletion of p53 by siRNA. mRNA expression values are normalized to GAPDH and siCtrl condition within each cell line. (C) Protein and conditioned media were harvested from cells after overnight incubation in reduced-serum conditions. Nitrocellulose membranes were stained with Ponceau S dye to visualize protein bands for loading control. Protein expression of pro-uPA (49 kDa) and its cleaved and activated forms B-chain (33 kDa) and A-chain (19 kDa) are shown in cell lysates and conditioned media. (D) Protein and E. mRNA expression of uPA (PLAU) following depletion of V157F mutp53 by siRNA.
Plau Mab1310 Primary Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plau mab1310 primary antibodies/product/R&D Systems
Average 92 stars, based on 1 article reviews
plau mab1310 primary antibodies - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

93
R&D Systems recombinant mouse plasminogen activator
<t>uPA</t> protein expression is mutp53-dependent. Protein expression of uPA encoded by the RNA-seq identified gene PLAU, was assessed <t>in</t> <t>p53-depleted</t> and control conditions. (A) Western blot of A549, H2087, H441, H2110 and H2009 cells transfected with negative control or siRNA directed against p53 (25 nM). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is shown as a loading control. (B) qRT–PCR was performed to evaluate mRNA expression of PLAU after depletion of p53 by siRNA. mRNA expression values are normalized to GAPDH and siCtrl condition within each cell line. (C) Protein and conditioned media were harvested from cells after overnight incubation in reduced-serum conditions. Nitrocellulose membranes were stained with Ponceau S dye to visualize protein bands for loading control. Protein expression of pro-uPA (49 kDa) and its cleaved and activated forms B-chain (33 kDa) and A-chain (19 kDa) are shown in cell lysates and conditioned media. (D) Protein and E. mRNA expression of uPA (PLAU) following depletion of V157F mutp53 by siRNA.
Recombinant Mouse Plasminogen Activator, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse plasminogen activator/product/R&D Systems
Average 93 stars, based on 1 article reviews
recombinant mouse plasminogen activator - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

94
Boster Bio 218 ncoa4 antibody
<t>uPA</t> protein expression is mutp53-dependent. Protein expression of uPA encoded by the RNA-seq identified gene PLAU, was assessed <t>in</t> <t>p53-depleted</t> and control conditions. (A) Western blot of A549, H2087, H441, H2110 and H2009 cells transfected with negative control or siRNA directed against p53 (25 nM). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is shown as a loading control. (B) qRT–PCR was performed to evaluate mRNA expression of PLAU after depletion of p53 by siRNA. mRNA expression values are normalized to GAPDH and siCtrl condition within each cell line. (C) Protein and conditioned media were harvested from cells after overnight incubation in reduced-serum conditions. Nitrocellulose membranes were stained with Ponceau S dye to visualize protein bands for loading control. Protein expression of pro-uPA (49 kDa) and its cleaved and activated forms B-chain (33 kDa) and A-chain (19 kDa) are shown in cell lysates and conditioned media. (D) Protein and E. mRNA expression of uPA (PLAU) following depletion of V157F mutp53 by siRNA.
218 Ncoa4 Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/218 ncoa4 antibody/product/Boster Bio
Average 94 stars, based on 1 article reviews
218 ncoa4 antibody - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

86
Santa Cruz Biotechnology urokinase plasminogen activator upa inhibitor
<t>uPA</t> protein expression is mutp53-dependent. Protein expression of uPA encoded by the RNA-seq identified gene PLAU, was assessed <t>in</t> <t>p53-depleted</t> and control conditions. (A) Western blot of A549, H2087, H441, H2110 and H2009 cells transfected with negative control or siRNA directed against p53 (25 nM). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is shown as a loading control. (B) qRT–PCR was performed to evaluate mRNA expression of PLAU after depletion of p53 by siRNA. mRNA expression values are normalized to GAPDH and siCtrl condition within each cell line. (C) Protein and conditioned media were harvested from cells after overnight incubation in reduced-serum conditions. Nitrocellulose membranes were stained with Ponceau S dye to visualize protein bands for loading control. Protein expression of pro-uPA (49 kDa) and its cleaved and activated forms B-chain (33 kDa) and A-chain (19 kDa) are shown in cell lysates and conditioned media. (D) Protein and E. mRNA expression of uPA (PLAU) following depletion of V157F mutp53 by siRNA.
Urokinase Plasminogen Activator Upa Inhibitor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/urokinase plasminogen activator upa inhibitor/product/Santa Cruz Biotechnology
Average 86 stars, based on 1 article reviews
urokinase plasminogen activator upa inhibitor - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

93
Proteintech anti prap1
<t>uPA</t> protein expression is mutp53-dependent. Protein expression of uPA encoded by the RNA-seq identified gene PLAU, was assessed <t>in</t> <t>p53-depleted</t> and control conditions. (A) Western blot of A549, H2087, H441, H2110 and H2009 cells transfected with negative control or siRNA directed against p53 (25 nM). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is shown as a loading control. (B) qRT–PCR was performed to evaluate mRNA expression of PLAU after depletion of p53 by siRNA. mRNA expression values are normalized to GAPDH and siCtrl condition within each cell line. (C) Protein and conditioned media were harvested from cells after overnight incubation in reduced-serum conditions. Nitrocellulose membranes were stained with Ponceau S dye to visualize protein bands for loading control. Protein expression of pro-uPA (49 kDa) and its cleaved and activated forms B-chain (33 kDa) and A-chain (19 kDa) are shown in cell lysates and conditioned media. (D) Protein and E. mRNA expression of uPA (PLAU) following depletion of V157F mutp53 by siRNA.
Anti Prap1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti prap1/product/Proteintech
Average 93 stars, based on 1 article reviews
anti prap1 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

90
R&D Systems quantikine human upar immunoassay
Figure 5. Interaction of suPAR and SMPDL3b. (A) Co-IP experiments performed in HEK293 cells showing an interaction between GFP- SMPDL3b and <t>FLAG-uPAR</t> (F-uPAR; upper panel) but not between GFP-SMPDL3b and FLAG-b3 integrin (F-b3; lower panel). FLAG- empty vector (F-C) was used as a negative control (upper panel). (B) Endogenous immunoprecipitation showing interaction of SMPDL3b and suPAR in glomeruli isolated from mice injected with PBS or LPS. E1, eluate from PBS-injected mice; E2, eluate from LPS-injected mice; I1, input (glomerular lysate) from PBS-injected mice; I2, input (glomerular lysate) from LPS-injected mice; IP, immunoprecipitation; WB, Western blot. (C) Competitive Co-IP experiments performed in HEK293 show that increasing amounts of GFP-SMPDL3b interfere with the interaction of FLAG-uPAR/suPAR and GFP-b3 integrin. However, transfection of GFP-empty vector used as a control does not affect the interaction between uPAR/suPAR and b3 integrin. GFP, green fluorescent protein.
Quantikine Human Upar Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/quantikine human upar immunoassay/product/R&D Systems
Average 90 stars, based on 1 article reviews
quantikine human upar immunoassay - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

85
R&D Systems and d systems cat baf1310
Figure 5. Interaction of suPAR and SMPDL3b. (A) Co-IP experiments performed in HEK293 cells showing an interaction between GFP- SMPDL3b and <t>FLAG-uPAR</t> (F-uPAR; upper panel) but not between GFP-SMPDL3b and FLAG-b3 integrin (F-b3; lower panel). FLAG- empty vector (F-C) was used as a negative control (upper panel). (B) Endogenous immunoprecipitation showing interaction of SMPDL3b and suPAR in glomeruli isolated from mice injected with PBS or LPS. E1, eluate from PBS-injected mice; E2, eluate from LPS-injected mice; I1, input (glomerular lysate) from PBS-injected mice; I2, input (glomerular lysate) from LPS-injected mice; IP, immunoprecipitation; WB, Western blot. (C) Competitive Co-IP experiments performed in HEK293 show that increasing amounts of GFP-SMPDL3b interfere with the interaction of FLAG-uPAR/suPAR and GFP-b3 integrin. However, transfection of GFP-empty vector used as a control does not affect the interaction between uPAR/suPAR and b3 integrin. GFP, green fluorescent protein.
And D Systems Cat Baf1310, supplied by R&D Systems, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/and d systems cat baf1310/product/R&D Systems
Average 85 stars, based on 1 article reviews
and d systems cat baf1310 - by Bioz Stars, 2026-05
85/100 stars
  Buy from Supplier

91
R&D Systems antibody against upa
Figure 5. Interaction of suPAR and SMPDL3b. (A) Co-IP experiments performed in HEK293 cells showing an interaction between GFP- SMPDL3b and <t>FLAG-uPAR</t> (F-uPAR; upper panel) but not between GFP-SMPDL3b and FLAG-b3 integrin (F-b3; lower panel). FLAG- empty vector (F-C) was used as a negative control (upper panel). (B) Endogenous immunoprecipitation showing interaction of SMPDL3b and suPAR in glomeruli isolated from mice injected with PBS or LPS. E1, eluate from PBS-injected mice; E2, eluate from LPS-injected mice; I1, input (glomerular lysate) from PBS-injected mice; I2, input (glomerular lysate) from LPS-injected mice; IP, immunoprecipitation; WB, Western blot. (C) Competitive Co-IP experiments performed in HEK293 show that increasing amounts of GFP-SMPDL3b interfere with the interaction of FLAG-uPAR/suPAR and GFP-b3 integrin. However, transfection of GFP-empty vector used as a control does not affect the interaction between uPAR/suPAR and b3 integrin. GFP, green fluorescent protein.
Antibody Against Upa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody against upa/product/R&D Systems
Average 91 stars, based on 1 article reviews
antibody against upa - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

Image Search Results


uPA protein expression is mutp53-dependent. Protein expression of uPA encoded by the RNA-seq identified gene PLAU, was assessed in p53-depleted and control conditions. (A) Western blot of A549, H2087, H441, H2110 and H2009 cells transfected with negative control or siRNA directed against p53 (25 nM). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is shown as a loading control. (B) qRT–PCR was performed to evaluate mRNA expression of PLAU after depletion of p53 by siRNA. mRNA expression values are normalized to GAPDH and siCtrl condition within each cell line. (C) Protein and conditioned media were harvested from cells after overnight incubation in reduced-serum conditions. Nitrocellulose membranes were stained with Ponceau S dye to visualize protein bands for loading control. Protein expression of pro-uPA (49 kDa) and its cleaved and activated forms B-chain (33 kDa) and A-chain (19 kDa) are shown in cell lysates and conditioned media. (D) Protein and E. mRNA expression of uPA (PLAU) following depletion of V157F mutp53 by siRNA.

Journal: Carcinogenesis

Article Title: The lung-enriched p53 mutants V157F and R158L/P regulate a gain of function transcriptome in lung cancer

doi: 10.1093/carcin/bgz087

Figure Lengend Snippet: uPA protein expression is mutp53-dependent. Protein expression of uPA encoded by the RNA-seq identified gene PLAU, was assessed in p53-depleted and control conditions. (A) Western blot of A549, H2087, H441, H2110 and H2009 cells transfected with negative control or siRNA directed against p53 (25 nM). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is shown as a loading control. (B) qRT–PCR was performed to evaluate mRNA expression of PLAU after depletion of p53 by siRNA. mRNA expression values are normalized to GAPDH and siCtrl condition within each cell line. (C) Protein and conditioned media were harvested from cells after overnight incubation in reduced-serum conditions. Nitrocellulose membranes were stained with Ponceau S dye to visualize protein bands for loading control. Protein expression of pro-uPA (49 kDa) and its cleaved and activated forms B-chain (33 kDa) and A-chain (19 kDa) are shown in cell lysates and conditioned media. (D) Protein and E. mRNA expression of uPA (PLAU) following depletion of V157F mutp53 by siRNA.

Article Snippet: The following antibodies were used to detect protein expression by western blot: p53 (DO-1, sc-126; Santa Cruz), p21 (C-19, sc-397, Santa Cruz) and uPA (AF1310, R&D systems).

Techniques: Expressing, RNA Sequencing, Control, Western Blot, Transfection, Negative Control, Quantitative RT-PCR, Incubation, Staining

Figure 5. Interaction of suPAR and SMPDL3b. (A) Co-IP experiments performed in HEK293 cells showing an interaction between GFP- SMPDL3b and FLAG-uPAR (F-uPAR; upper panel) but not between GFP-SMPDL3b and FLAG-b3 integrin (F-b3; lower panel). FLAG- empty vector (F-C) was used as a negative control (upper panel). (B) Endogenous immunoprecipitation showing interaction of SMPDL3b and suPAR in glomeruli isolated from mice injected with PBS or LPS. E1, eluate from PBS-injected mice; E2, eluate from LPS-injected mice; I1, input (glomerular lysate) from PBS-injected mice; I2, input (glomerular lysate) from LPS-injected mice; IP, immunoprecipitation; WB, Western blot. (C) Competitive Co-IP experiments performed in HEK293 show that increasing amounts of GFP-SMPDL3b interfere with the interaction of FLAG-uPAR/suPAR and GFP-b3 integrin. However, transfection of GFP-empty vector used as a control does not affect the interaction between uPAR/suPAR and b3 integrin. GFP, green fluorescent protein.

Journal: Journal of the American Society of Nephrology

Article Title: Sphingomyelinase-Like Phosphodiesterase 3b Expression Levels Determine Podocyte Injury Phenotypes in Glomerular Disease

doi: 10.1681/asn.2013111213

Figure Lengend Snippet: Figure 5. Interaction of suPAR and SMPDL3b. (A) Co-IP experiments performed in HEK293 cells showing an interaction between GFP- SMPDL3b and FLAG-uPAR (F-uPAR; upper panel) but not between GFP-SMPDL3b and FLAG-b3 integrin (F-b3; lower panel). FLAG- empty vector (F-C) was used as a negative control (upper panel). (B) Endogenous immunoprecipitation showing interaction of SMPDL3b and suPAR in glomeruli isolated from mice injected with PBS or LPS. E1, eluate from PBS-injected mice; E2, eluate from LPS-injected mice; I1, input (glomerular lysate) from PBS-injected mice; I2, input (glomerular lysate) from LPS-injected mice; IP, immunoprecipitation; WB, Western blot. (C) Competitive Co-IP experiments performed in HEK293 show that increasing amounts of GFP-SMPDL3b interfere with the interaction of FLAG-uPAR/suPAR and GFP-b3 integrin. However, transfection of GFP-empty vector used as a control does not affect the interaction between uPAR/suPAR and b3 integrin. GFP, green fluorescent protein.

Article Snippet: The biopsy tissue specimens were manually microdissected,41–43 and glomerular gene expression profiling was performed as previously described.15 Measurements of suPAR Circulating suPAR levels were determined in the sera from 53 patients with FSGS from the FSGS clinical trial25 and 30 patients with type 1 diabetes and normoalbuminuria, 34 patients with type 1 diabetes and microalbuminuria, and 10 patients with type 1 diabetes and macroalbuminuria from the FinnDiane study cohort using Quantikine Human uPAR Immunoassay (R&D Sys- tems) performed following the manufacturer’s protocol.

Techniques: Co-Immunoprecipitation Assay, Plasmid Preparation, Negative Control, Immunoprecipitation, Isolation, Injection, Western Blot, Transfection, Control